12/1
08:10 am
prqr
ProQR to Participate in 8th Annual Evercore Healthcare Conference [Yahoo! Finance]
High
Report
ProQR to Participate in 8th Annual Evercore Healthcare Conference [Yahoo! Finance]
12/1
08:00 am
prqr
ProQR to Participate in 8th Annual Evercore Healthcare Conference
High
Report
ProQR to Participate in 8th Annual Evercore Healthcare Conference
11/15
10:33 am
prqr
ProQR Therapeutics (NASDAQ:PRQR) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.
Medium
Report
ProQR Therapeutics (NASDAQ:PRQR) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.
11/6
07:00 am
prqr
ProQR Announces Third Quarter 2025 Operating and Financial Results
Medium
Report
ProQR Announces Third Quarter 2025 Operating and Financial Results
11/4
08:42 am
prqr
ProQR Therapeutics (NASDAQ:PRQR) had its "buy" rating reaffirmed by analysts at Chardan Capital. They now have a $4.00 price target on the stock.
Medium
Report
ProQR Therapeutics (NASDAQ:PRQR) had its "buy" rating reaffirmed by analysts at Chardan Capital. They now have a $4.00 price target on the stock.
10/20
08:00 am
prqr
ProQR Receives CTA Authorization for AX-0810 and Announces Virtual Investor and Analyst Event on November 3, 2025
Low
Report
ProQR Receives CTA Authorization for AX-0810 and Announces Virtual Investor and Analyst Event on November 3, 2025
10/17
05:44 am
prqr
ProQR Therapeutics (NASDAQ:PRQR) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
Medium
Report
ProQR Therapeutics (NASDAQ:PRQR) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
10/13
08:39 am
prqr
ProQR to Participate in Upcoming Investor Conferences in October 2025 [Yahoo! Finance]
Low
Report
ProQR to Participate in Upcoming Investor Conferences in October 2025 [Yahoo! Finance]
10/13
08:30 am
prqr
ProQR to Participate in Upcoming Investor Conferences in October 2025
Medium
Report
ProQR to Participate in Upcoming Investor Conferences in October 2025